Adani Wilmar’s Q3 Results: Profit Doubles to ₹411 Crore Amid Strong Demand Surge

---

Adani Wilmar Ltd has reported a remarkable financial performance for the third quarter of FY25, with its net profit soaring to ₹411 crore, more than doubling compared to ₹200.89 crore in the same quarter last year.

This impressive growth of 104.55% reflects the company’s strong positioning in the edible oils and food sectors, driven by robust consumer demand.

The company announced its Q3 results on January 27, 2025, revealing total revenue from operations of ₹16,859 crore, marking a 31% increase from ₹12,828 crore in Q3 FY24.

The operating EBITDA also reached new heights, recording ₹792 crore, a significant rise of 57% year-on-year.Key highlights from Adani Wilmar’s Q3 performance include:

• Edible Oils Segment: Revenue surged by 38%, reaching ₹13,387 crore, despite a slight decline in branded sales due to lower packed palm oil sales. Overall volume in this segment grew by 4% year-on-year.
• Food and FMCG Segment: This segment recorded revenue of ₹1,558 crore, up 22%, benefiting from strong growth in both general trade and e-commerce channels.
• Distribution Expansion: Adani Wilmar has significantly expanded its distribution network, now reaching over 43,000 rural towns, up from just 5,000 in March 2022. The company aims to extend this reach to over 50,000 towns by the end of FY25.

Angshu Mallick, Managing Director and CEO of Adani Wilmar, highlighted the company’s strategic initiatives that have driven growth.

He noted that e-commerce sales volume grew by an impressive 41% year-on-year, reflecting the company’s adaptability to changing consumer preferences.

The stock market reacted positively to these results, with Adani Wilmar shares rising approximately 7.21%, hitting a high of ₹270 following the announcement.

As Adani Wilmar continues to build on its strengths and expand its market presence, investors are optimistic about the company’s future growth trajectory in the competitive food and FMCG landscape.

Also Read

Denta Water IPO Oversubscribed Over 221 Times, Reflecting Strong Investor Demand

Dr. Agarwal’s Health Care Limited Set to Launch IPO: A Promising Investment Opportunity